peror
plantmad
vaccin
appear
part
widerang
proposit
name
obtain
prepar
medicalbiolog
assign
use
genet
engin
biopharm
base
plantbas
vaccin
pmv
dispos
genet
transform
plant
differ
method
includ
agrobacteri
transform
via
agrobacterium
tumefacien
plasmid
harbor
genet
construct
gene
interest
regulatori
gene
due
intrins
nativ
capabl
tumefacien
dna
transfer
plant
possibl
transfer
gene
interest
success
plant
organ
methodolog
agrobacteri
transfer
recombin
tdna
plant
render
success
import
transgen
plant
creat
produc
protein
medic
destin
somatotropin
serum
albumin
epiderm
growth
factor
hirudin
erythropoietin
glucocerebrosidas
cytokin
lactoferrin
entir
row
compound
direct
rapidli
develop
therapeut
protein
produc
transgen
plant
amount
serious
extend
fischer
eman
stabli
inherit
next
gener
classic
agrobacteri
transform
consist
insert
singl
copi
tdna
genom
host
plant
follow
integr
stabil
integr
structur
plant
host
genom
support
select
grow
explant
next
seed
gener
nutrit
media
high
content
select
antibiot
obtain
transgen
plant
synthes
foreign
protein
gener
experi
treat
explant
strong
select
medium
high
concentr
kanamycin
initi
creation
peror
vaccin
base
transgen
plant
proclaim
prophylaxi
children
hepat
b
needlefre
vaccin
suppos
reason
altern
vaccin
via
inject
accord
world
health
organ
inject
vaccin
reveal
million
case
contamin
hepat
b
million
contamin
hepat
c
hiv
contamin
million
case
bacteri
contamin
infect
site
abscess
kwon
et
al
initi
creat
peror
vaccin
brought
great
interest
receiv
broad
develop
shown
transgen
plant
insert
gene
interest
appear
system
mani
antigen
protein
danger
virus
bacteri
contagi
agent
might
produc
year
start
initi
creation
peror
socal
initi
edibl
vaccin
pmv
develop
rang
seriou
diseas
follow
enterotoxigen
escherichia
coli
vibrio
cholera
plasmodium
falciparum
footandmouth
diseas
rabi
viru
norwalk
viru
rotaviru
hepat
b
viru
hepat
c
viru
hepat
viru
measl
rubella
human
immunodefici
viru
staphylococcu
aureu
rhinoviru
papillomaviru
cytomegaloviru
pseudomona
aeruginosa
respiratori
syncyti
viru
influenza
viru
bacillu
anthraci
hemorrhag
viru
gastroenter
viru
pneumonia
pasteurellosi
parvoviru
mani
other
streatfield
howard
year
made
attempt
develop
pmv
danger
diseas
particular
binari
vaccin
hepat
b
salyaev
et
al
salyaev
et
al
shchelkunov
et
al
anoth
hepat
b
salyaev
et
al
investig
author
carri
mostli
fundament
characterist
research
transgen
plant
base
nuclear
agrobacteri
transform
often
produc
low
amount
antigen
protein
nevertheless
known
exampl
high
express
foreign
protein
plant
phytas
tobacco
total
solubl
protein
tsp
eubacteri
glucanas
arabidopsi
tsp
rule
gener
nuclear
stabl
transform
provid
product
foreign
gene
interest
transgen
plant
level
tsp
follow
b
subunit
thermolabil
entherotoxin
e
coli
ltb
tsp
hbsag
hbv
tsp
glycoprotein
coronaviru
transmiss
gastroenter
tsp
human
serum
albumin
tsp
human
complement
c
protein
tsp
epiderm
growth
factor
tsp
erythropoietin
tsp
fresh
weight
streatfield
howard
regardless
low
product
target
protein
almost
produc
pmv
foreign
protein
immunoreact
capabl
activ
immun
respons
experiment
anim
volunt
signific
fact
experi
appear
immunogen
properti
well
prevent
disposit
antigen
protein
synthes
transgen
plant
concentr
rang
fresh
weight
streatfield
howard
later
shown
pmv
capabl
induc
mucos
gener
system
immun
respons
mammal
due
mani
posit
characterist
pmv
need
switch
commerci
level
howev
mention
previous
standard
agrobacteri
transform
low
product
rule
owe
insert
singl
copi
tdna
facilit
high
product
synthesi
antigen
protein
per
unit
plant
mass
moreov
use
viru
gene
express
construct
integr
genom
host
plant
appear
epigenet
disord
result
chimer
silenc
phenomenon
well
document
present
time
call
rna
interfer
rnai
lead
virusinducedgenesilenc
vig
function
natur
defens
antiviru
mechan
stanford
univers
j
sanford
propos
idea
fast
effect
plant
transform
use
process
bioballist
dna
target
gene
recombin
plasmid
place
upon
tungsten
gold
microprojectil
place
onto
surfac
teflon
macroprojectil
shot
onto
plant
object
method
receiv
signific
develop
plant
might
transform
way
also
studi
object
mice
frog
rat
organ
method
name
biolist
subsequ
method
gene
gun
differ
design
work
base
inert
gase
helium
argon
occupi
main
posit
biotechnolog
transgen
plant
method
allow
shoot
larg
recombin
plasmid
high
express
construct
klein
et
al
product
synthes
antigen
protein
increas
time
method
mere
elabor
h
daniel
cowork
chan
daniel
creat
transgen
homoplasmictransplastom
plant
high
antigen
product
also
protein
enzym
replac
therapi
use
human
product
construct
made
daniel
cowork
creation
polycistron
join
target
gene
marker
gene
flank
recombin
fragment
gene
intergen
region
plastid
host
plant
placement
target
gene
cistron
sequenc
plastid
genom
allow
increas
yield
target
gene
crystal
toxic
protein
bacillu
thuringiensi
tsp
even
tobacco
leav
de
cosa
et
al
tabl
show
express
plastid
construct
exceed
time
express
nuclear
transform
mention
plastid
transform
use
select
marker
gene
kanamycin
resist
nptii
result
increas
select
enzym
tsp
vaccin
prepar
doubt
valu
account
high
content
enzym
resist
antibiot
complex
system
plastid
transform
develop
p
maliga
combin
first
time
agrobacteri
plastid
transform
place
construct
nuclear
express
vector
gene
target
leader
larg
subunit
rubisco
transport
geneprotein
interest
plastid
way
possibl
increas
product
tetanu
toxin
tetc
place
promot
pprrn
regulatori
element
atpbtrbcl
tsp
maliga
nevertheless
plastid
transform
still
labori
timeconsum
method
need
signific
financi
support
howev
principl
combin
method
transform
occur
use
perspect
use
construct
plant
viru
gene
regulatori
element
attract
long
time
high
potenti
product
synthesi
heterolog
protein
possibl
add
incorpor
regulatori
element
plant
virus
express
vector
plant
transform
increas
effici
product
target
protein
transgen
plant
neg
featur
virusbas
construct
instabl
order
save
virusbas
vector
unrel
chang
come
environment
stress
yu
gleba
cowork
elabor
combin
agrobacteri
vector
destruct
part
tmv
genom
one
plant
viru
express
vector
method
name
magnifect
insert
rnadepend
rna
polymeras
rdrp
provid
increas
synthesi
rna
replicon
rna
amplim
serv
templat
synthesi
target
protein
case
accumul
target
protein
increas
tsp
marillonnet
et
al
thu
develop
parallel
method
plastid
nuclear
transform
join
result
high
product
method
plant
transform
obtain
suitabl
demand
commerci
product
industri
protein
vaccin
antibodi
therapeut
biomolecul
komarova
et
al
marillonnet
et
al
differ
exampl
genet
transform
plant
list
paper
chan
daniel
employ
edibl
plant
part
vaccin
materialwhos
toxic
practic
close
zero
due
absenc
cryptic
pathogen
potenti
danger
human
prion
harm
plant
virus
microbi
pathogensi
advis
point
view
transgenesi
recombin
plant
featur
elicit
allergi
might
potenti
reveal
well
elicit
differ
type
autoimmun
diseas
cardiovascular
collaps
disord
central
nervou
system
howev
point
view
express
system
bacteri
baculovir
yeast
appear
chanc
realiz
cryptic
danger
properti
result
recombin
exampl
presenc
silenc
transposon
retroposon
capabl
evok
seriou
diseas
epigenet
charact
therefor
even
sophist
posit
plant
express
system
safer
significantli
reliabl
candid
product
recombin
protein
well
peror
vaccin
fig
exampl
differ
express
system
present
employ
present
time
biopharm
product
target
protein
differ
destin
divers
extent
plant
express
system
best
accord
opinion
mani
author
peyret
lomonossoff
owe
safeti
low
cost
easier
shift
scalabl
well
appropri
fold
glycosyl
process
posttransl
modif
protein
synthes
mention
investig
employ
destruct
plant
virus
rna
virus
dna
virus
equal
attract
signific
interest
past
year
activ
viru
enzym
replicas
rnadepend
rna
polymeras
use
work
sequenc
place
frame
gene
interest
genet
construct
promot
cauliflow
mosaic
viru
camv
capabl
transcrib
polycistron
sequenc
chan
daniel
b
streatfield
howard
gene
employ
also
facilit
episom
express
foreign
gene
plant
similar
bacteri
plasmid
dna
virus
mammal
peyret
lomonossoff
construct
place
space
rb
lb
tdna
control
viru
segment
stabil
process
transform
tdna
disarm
process
free
plant
oncogen
viru
gene
encod
synthesi
move
protein
capsid
protein
place
construct
pseudovirion
form
extend
throughout
plant
replicas
rdrp
synthesi
first
primari
transcript
occur
suppos
nucleu
move
cytoplasm
readi
effect
enzym
initi
process
replic
sequenc
follow
downstream
fig
larg
amount
amplicon
form
join
circl
therefor
formid
amount
replisom
appear
serv
templat
synthesi
antigen
protein
well
target
protein
biomolecul
usag
plant
translat
machineri
rapid
effect
continu
rate
around
sever
microgram
target
protein
per
g
fresh
weight
accumul
plant
tissu
day
agrobacteri
infect
howev
infect
plant
usual
die
day
appear
viru
sequenc
plant
cell
evok
usual
phenomenon
rnai
order
escap
rnai
viru
genom
sequenc
encod
viru
proteinantisilenc
might
place
genet
construct
placement
essenti
increas
product
target
antigen
protein
protein
synthes
system
thu
use
plant
viru
express
vector
significantli
promot
sharp
increas
amount
antigen
protein
obtain
vaccin
materi
amount
antigen
protein
exce
amount
antigen
protein
obtain
biolist
method
vaccin
antigen
protein
creat
plant
viru
express
system
consid
glycosyl
signific
amount
site
glycosyl
surfac
antigen
protein
deriv
natur
mani
site
glycosyl
viru
capsid
protein
gp
virus
show
real
evid
overal
glycosyl
mani
famili
plant
glycosyltransferas
found
function
bind
xenobiot
order
withdraw
bound
state
vacuol
space
transport
aim
secret
therebi
detoxifi
uncondit
antigen
viru
protein
danger
viru
pathogen
much
plant
transgen
practic
show
friendli
protein
plant
metabol
howev
possibl
distinct
limit
plant
cell
surviv
antigen
viru
protein
might
bind
fast
synthes
conjug
activ
glucos
abund
sourc
plant
cell
set
udptransferas
glucosid
residu
gene
ugt
isol
green
plantlet
zea
may
l
method
screen
posit
clone
cdna
librari
lambda
zap
ii
stratagen
usa
corn
antibodi
grown
rabbit
serum
iaasynthas
udpgtransferas
michigan
state
univers
done
laboratori
head
professor
rs
bandurski
particip
rekoslavskaya
et
al
accord
professor
rs
bandurski
szerszen
et
al
udpgtransferas
play
signific
role
growth
develop
plant
plant
hormon
metabol
secondari
compound
bind
lipid
phenol
peptid
protein
perciv
bandurski
gener
scheme
particip
udpgtransferaseencod
gene
ugt
iaaglucos
synthas
differ
process
plant
glycosyl
antigen
protein
mark
one
star
increas
immun
respons
vaccin
mark
two
star
challeng
interest
design
develop
pmv
fig
begin
experi
obtain
transgen
plant
ugt
gene
specif
activ
udpgtransferas
increas
significantli
accord
data
activ
udpgtransferas
increas
nmol
mg
protein
per
hour
tomato
rekoslavskaya
et
al
nmolmg
protein
per
hour
potato
salyaev
et
al
consequ
signific
part
protein
transgen
plant
undergo
process
glycosyl
circumst
see
consider
connect
glycosyl
process
vaccin
import
valu
essenti
mediat
downstream
function
mention
previous
transgen
plant
express
signific
amount
select
protein
give
resist
antibiot
tsp
undesir
therefor
elabor
method
select
regener
tomato
transgen
plant
medium
murasig
skoog
ms
contain
mgl
acid
select
gene
ugt
insert
genet
construct
instead
nptii
capabl
root
format
explant
tomato
transgen
plant
gene
ugt
control
ms
medium
mgl
shown
fig
control
explant
abl
form
root
ms
medium
transgen
explant
root
normal
select
transgen
plant
grew
success
gave
good
harvest
fig
use
tomato
fruit
transform
genet
construct
human
papillomaviru
type
major
capsid
protein
l
work
obtain
adequ
plant
regener
gene
failedaft
transfer
vitro
soil
greenhous
select
regener
die
soon
seen
work
de
la
rosa
et
al
transgen
plant
larg
amount
regener
gene
surviv
select
plant
reduc
gener
develop
form
small
fruit
therefor
use
transform
directli
fruit
inject
agrobacteri
suspens
gene
basal
part
fruit
hongli
et
al
made
transform
tobacco
leaf
disk
obtain
select
regener
grown
regener
extract
buffer
extract
freezedri
dri
materi
dialyz
prepar
obtain
use
vaccin
order
studi
immunogen
mice
antibodi
respons
weak
mice
vaccin
four
time
dose
mkg
elisa
read
lower
unit
optic
densiti
measur
order
improv
immun
respons
mice
given
thermolabil
nontox
ltb
subunit
b
enteropathogen
e
coli
immun
respons
increas
greatli
combin
administr
vaccin
materi
ltb
mice
serum
howev
found
use
ltb
peror
vaccin
result
destruct
gastroenter
tissu
mice
reveal
bloodi
swell
sinc
tomato
fruit
contain
great
number
natur
adjuv
tomatin
lycopersicin
esculetin
lycopen
tomatidin
necess
work
add
artifici
adjuv
induct
activ
immun
respons
mice
vaccin
moreov
work
de
la
rosa
et
al
intact
freezedri
ground
materi
tomato
fruit
without
isol
purif
antigen
protein
use
mice
vaccin
work
group
found
manipul
isol
purif
concentr
vacuum
concentr
antigen
protein
well
sd
electrophoresi
result
instabl
loss
immunogen
immunogen
capabl
antigen
protein
depend
correct
natur
orient
linear
conform
epitop
quaternari
protein
structur
chemic
electrostat
forc
held
natur
conform
epitop
viru
capsid
strong
enough
resist
given
impact
excess
strength
bind
amino
acid
antigen
protein
exampl
heat
min
microwav
oven
unpublish
data
well
use
salt
denatur
buffer
system
immunogen
bind
antibodi
vivo
effector
molecul
complementa
well
mucos
immun
structur
gut
epitheli
cell
line
galt
mucos
associ
lymphoid
tissu
malt
lymphoid
tissueswa
destroy
perhap
reason
use
vaccin
materi
high
dose
viruslik
particl
vlp
larg
quantiti
mkg
antigen
protein
vaccin
wellknown
commerci
vaccin
gardasil
cervarix
pseudovirion
sorb
amorph
hydroxyphosph
sulfat
aluminum
adjuv
properti
hard
condit
vaccin
gardasil
explain
appear
entir
row
side
effect
statist
vaccin
known
death
case
per
vaccin
individu
usag
high
dose
vaccin
new
interest
behavior
antigen
protein
hpv
appear
high
concentr
abl
induc
crossreact
interact
antibodi
type
bissett
et
al
previous
standard
vaccin
vaccin
obtain
bacteri
baculovir
system
phenomenon
crossreact
interact
antibodi
antigen
unknown
actual
revers
observ
induc
immun
respons
one
type
hpv
suitabl
type
hpv
immun
antibodi
reveal
strong
specif
one
particular
type
hpv
spare
commerci
suitabl
method
concentr
antigen
protein
freezedri
even
littl
loss
immunogen
occur
posit
result
immun
respons
receiv
dri
raw
vaccin
materi
stream
warm
air
read
elisa
given
high
titer
log
blood
serum
mice
vaccin
airdri
vaccin
materi
tomato
fruit
unpublish
data
immunogen
antigen
protein
main
condit
success
vaccin
therefor
sever
mean
techniqu
avail
order
increas
immunogen
hooper
wolfert
boon
major
histocompat
complex
mhc
class
ii
resid
glycoprotein
present
antigen
peptid
epitop
cell
surfac
recognit
bind
circul
lymphocyt
wolfert
boon
therefor
import
consid
modif
antigen
protein
glycon
uptak
proteolyt
cleavag
present
mhc
follow
activ
prime
cell
thu
glycosyl
antigen
protein
import
vaccin
develop
key
protein
involv
recognit
antigen
follow
orchestr
mean
harmon
interact
effector
function
combin
glycosyl
wolfert
boon
therefor
glycosyl
great
import
reaction
involv
immun
respons
known
peyret
lomonossoff
glycosyl
protein
descend
plant
cell
close
approxim
immun
respons
mammal
bacteria
similar
glycosyl
yeast
type
glycosyl
differ
mammal
human
baculovir
express
system
distant
type
glycosyl
satisfi
weakli
glycosyl
protein
mammal
antigen
glycoprotein
immun
tissu
mammal
form
spatial
nanostructur
lattic
type
dendrim
like
attract
nanostructur
b
lymphocyt
dendrit
cell
dc
compon
cellmedi
immunogen
exist
dendrimer
nanostructur
glycan
antigen
protein
allow
pass
immunogen
zone
undermucos
layer
name
lamina
propria
b
lymphocyt
dc
whole
zone
play
import
role
immunogen
though
previous
suppos
lamina
propria
evid
structur
immunogen
format
similar
lymphoid
tissu
cell
peyer
aggreg
lymphat
follicl
call
patch
thu
glycoprotein
dendrit
immunogen
structur
antigen
consid
transport
solubl
stabl
effect
mobil
nanostructur
involv
immun
respons
comparison
cell
structur
cell
peyer
patch
glycosyl
antigen
viru
protein
correspond
defens
factor
viru
particl
allow
escap
immun
system
host
cell
mask
receptor
exampl
capsid
protein
site
bind
glycosid
residu
glycosyl
capsid
protein
allow
make
departur
proteas
antibodi
first
barrier
defens
host
cell
key
function
recognit
foreign
antigen
protein
resid
dc
due
function
structur
receptor
domain
metabol
form
adapt
reaction
immun
system
mammal
begin
centuri
recognit
consid
right
specif
hiv
virion
made
dc
mean
newli
found
knowledg
represent
role
dc
initi
immun
respons
adapt
answer
pathogen
significantli
extend
dc
structur
circul
extracellular
space
tissu
find
bind
polysaccharid
polyglycan
lipopolysaccharid
molecul
surfac
invad
pathogen
bacteria
virus
microfungi
purpos
dc
glycosyl
receptor
site
abl
form
divers
polyglucosid
bond
polysaccharid
polyglycan
protein
result
format
pentam
complic
polyglycan
dendrimer
structur
lattic
give
dendrimer
nanostructur
distinct
stabil
transport
well
safeti
anticipatori
action
proteas
fate
nanostructur
well
known
event
intern
enter
lysosom
partial
cleavag
proteas
present
epitop
cell
surfac
recognit
receptor
b
lymphocyt
induc
way
synthesi
specif
antibodi
wolfert
boon
dc
abl
interact
polyglycan
structur
endobiot
human
glycom
transfer
reaction
immun
cell
question
aris
dc
choos
protein
pathogen
instead
host
protein
key
role
recognit
play
densiti
glycosyl
protein
heavi
glycosyl
take
place
surfac
antigen
protein
possibl
captur
bound
dc
wolfert
boon
glycosyl
play
key
role
address
protein
synthes
er
socal
cotransl
glycosyl
core
oligosaccharid
compos
two
residu
nacetylglucosamin
nine
residu
mannos
three
glucos
residu
join
n
asp
n
site
newli
synthes
protein
lehning
et
al
oligosaccharid
form
phosphat
donor
molecul
dolichol
phosphat
isoprenoid
deriv
dock
membran
er
nlink
oligosaccharid
retain
pentasaccharid
core
deriv
origin
residu
oligosaccharid
move
protein
golgi
complex
transferas
involv
glycosyl
udpnacetylglucosamin
udpmannos
udpg
cofactor
locat
intern
lumin
surfac
er
catalyz
glycosyl
cytosol
protein
time
sort
er
cytosol
resid
protein
take
place
difficult
say
specif
transferas
glycosyl
residu
bind
udp
gdp
adp
accord
unpublish
data
transferas
zea
may
l
encod
ugt
gene
use
equal
udpg
adpg
transgen
potato
plant
found
dc
respons
specif
antigen
present
apc
present
drive
primari
immun
respons
express
receptor
mannos
surfac
fact
point
directli
interact
glycosyl
antigen
protein
made
plant
express
viru
system
immunogen
dc
high
extent
protein
glycosyl
mammal
provid
transferas
glycosidas
per
cell
moreov
approxim
high
reactiv
pentamer
structur
glycosid
high
capabl
bind
effector
molecul
complement
antibodi
other
found
mammalian
cell
therefor
dc
chose
heavili
glycolyz
protein
surfac
cell
intracellular
mucos
space
virus
high
glycosyl
capsid
protein
bacteria
microfungi
surfac
polysaccharid
lipopolysaccharid
enter
mucos
tissu
line
malt
galt
anogenit
tissu
tear
channel
talt
conjunct
tissu
calt
nasalpharyng
tissu
nalt
thu
dc
provid
sort
choic
cell
protein
structur
deliveri
immun
cell
induct
immun
respons
skin
anogenit
wart
known
even
time
ancient
rome
greec
assum
anogenit
wart
consequ
lascivi
way
life
interchang
sexual
partner
middl
age
accord
analysi
church
book
found
virgin
nun
widow
honest
behavior
never
papillomatosi
cervic
cancer
year
causeandeffect
relat
establish
cervic
cancer
papillomavirus
vaccin
human
papillomavirus
hpv
creat
depress
immun
system
encourag
extens
cancerogenesi
due
hpv
infect
therefor
papillomaviru
infect
often
combin
hivinfect
tuberculosi
hepat
b
hard
process
type
herp
danger
diseas
fact
evid
possibl
pandem
statu
high
oncogen
type
hpv
associ
danger
virus
prompt
problem
actual
creation
vaccin
new
gener
oncogen
type
papillomavirus
main
pathogen
agent
danger
diseas
cervic
cancer
around
women
die
annual
numer
attempt
conduct
creat
prevent
therapeut
vaccin
papillomavirus
numer
laboratori
world
although
two
prevent
inject
vaccin
gardasil
merck
cervarix
glaxosmithklin
set
expans
papillomavirus
still
progress
known
compani
merck
usa
develop
appli
us
food
drug
administr
author
quadrival
inject
vaccin
countri
world
result
mass
vaccin
statist
reveal
death
per
vaccin
women
mean
one
woman
girl
die
vaccin
women
alarm
enough
indic
vaccin
gardasil
perhap
fact
explain
presenc
hydroxyphosph
sulfat
aluminum
adjuv
aluminum
salt
toxic
human
anoth
inject
vaccin
name
cervarix
glaxosmithklin
work
base
baculovir
express
system
insect
cell
fall
armyworm
spodoptera
frugiperda
lepidoptera
express
system
insect
cell
fall
armyworm
fold
major
capsid
protein
occur
quit
differ
fold
nativ
hpv
capsid
therefor
antigen
protein
produc
baculovir
express
system
might
induc
synthesi
antibodi
would
reliabl
recognit
nativ
threedimension
structur
capsid
protein
virion
hpv
perhap
reason
case
gardasil
use
administr
high
dose
mkg
antigen
protein
togeth
adjuv
lipid
endur
vaccin
accord
data
scientif
literatur
year
connect
expans
papillomaviru
infect
around
world
biotyp
hpv
structur
gene
regul
activ
studi
well
fundament
item
interact
hpv
gene
initi
cancerogenesi
past
year
studi
structur
regul
gene
express
process
clear
virion
reach
real
progress
occur
approxim
year
first
infect
papillomaviru
human
normal
immun
system
without
follow
reinfect
expans
cervic
intraepitheli
neoplasia
cin
taken
place
howev
case
integr
oncogen
gene
took
place
result
event
connect
neoplasia
increas
earli
gene
earli
protein
shown
control
integr
oncogen
influenc
principl
regulatori
action
initi
cancerogenesi
fig
increas
amount
capsid
protein
facilit
increment
selfassembl
virion
particl
transfer
golgi
net
bud
mammalian
cell
via
exocytosi
full
size
viru
process
appear
final
step
clear
viru
particl
thu
interact
protein
result
liber
cell
hpv
virion
evid
capsid
protein
invok
reduct
amount
protein
feedback
thu
decreas
synthesi
follow
conduct
fundament
work
studi
intrins
aspect
neoplasia
initi
import
signific
real
danger
expans
even
pandem
papillomavirus
diseas
world
countri
monitor
papillomaviru
infect
peopl
carri
exampl
itali
annual
detriment
economi
diseas
associ
papillomavirus
count
constitut
million
euro
baio
et
al
even
year
ago
made
prognosi
expans
hpv
infect
women
reach
year
expans
hpv
grow
reach
around
infect
women
exist
prevent
vaccin
give
signific
effect
free
neg
side
featur
tradit
prevent
vaccin
abl
provid
defens
papillomavirus
also
side
effect
follow
necessari
continu
develop
vaccin
new
innov
gener
high
effect
safeti
particular
vaccin
base
transgen
plant
socal
pmv
alreadi
satisfi
demand
numer
posit
characterist
demonstr
mani
time
develop
vaccin
necess
increas
content
antigen
protein
matter
greatest
import
made
attempt
develop
variant
plant
express
system
synthesi
antigen
protein
high
oncogen
risk
control
promot
camv
sequenc
omega
leader
tobacco
mosaic
viru
translat
enhanc
tmv
salyaev
et
al
usag
tmv
genet
construct
result
signific
increas
product
antigen
protein
tomato
fruit
infect
suspens
tumefacien
tmv
sequenc
tmv
compil
base
pair
guauuuuuacaacaauuaccaacaacaacaaa
caauuacuauuuacaauuaca
shirokikh
et
al
omega
leader
tmv
tmv
highlyeffici
enhanc
translat
due
unic
structur
consecut
featur
central
core
part
consist
repeat
cytidyl
adenyl
residu
caa
compil
half
whole
sequenc
omega
leader
repeat
caa
residu
form
stabl
tripl
helix
differ
form
classic
canon
watson
crick
pair
guanil
residu
instead
c
connect
one
hydrogen
bound
leader
sequenc
tripl
helix
bind
ribosom
enhanc
translat
tmv
abl
increas
translat
homolog
heterolog
rna
cell
differ
type
shirokikh
et
al
genet
construct
target
gene
place
promot
camv
fig
sequenc
tmv
put
untransl
region
serv
enhanc
translat
termin
toc
gene
oc
encod
octopin
synthas
agrobacteri
tdna
use
construct
poli
sign
present
construct
untransl
region
synthesi
genet
construct
carri
compani
genscript
usa
genet
transform
tomato
fruit
conduct
inject
method
suspens
tumefacien
tmv
directli
maxim
result
ngmg
tsp
reach
hybrid
tomato
fruit
name
socal
pink
flamingo
fig
mention
previou
work
without
omega
leader
content
antigen
protein
tomato
fruit
ngmg
tsp
case
tbihb
antigen
ngmg
tsp
case
antigen
thu
usag
sequenc
tmv
enhanc
translat
significantli
increas
product
antigen
protein
comparison
earlier
construct
use
without
tmv
gave
us
possibl
obtain
vaccin
materi
preclin
trial
creat
candid
vaccin
new
interest
direct
appear
creation
panvaccin
induc
broadli
neutral
antibodi
develop
basi
minor
capsid
protein
known
sinc
earlier
work
role
minor
capsid
protein
insignific
involv
keep
major
capsid
protein
lattic
capsid
hpv
state
capsid
pentam
hold
loop
band
right
natur
posit
save
critic
epitop
minor
capsid
protein
differ
major
capsid
protein
never
reveal
strong
specif
type
hpv
molecul
situat
insid
protein
shield
later
becam
clear
minor
protein
play
critic
role
save
hpv
virion
first
immun
respons
allow
interact
immun
receptor
host
mammal
cell
basi
phenomenon
lie
abil
minor
protein
expos
temporari
epitop
furin
cleavag
pentam
first
step
infect
react
cell
receptor
recogn
receptor
whole
event
block
follow
initi
defens
process
antigen
variabl
protein
low
analysi
crossreact
antibodi
highli
conserv
sequenc
amino
acid
residu
found
minim
linear
epitop
amino
acid
residu
recogn
broadli
neutral
antibodi
specif
type
hpv
contain
insert
capsidform
carrier
core
antigen
nontox
mutant
diphtheria
toxin
genet
construct
obtain
express
panvaccin
e
coli
high
product
type
hpv
thu
author
announc
broadli
neutral
panvaccin
hpv
defens
safeti
wang
et
al
vaccinolog
recent
time
particular
attent
paid
creation
therapeut
type
vaccin
appli
prevent
vaccin
differ
diseas
well
cancer
prevent
weak
differ
approach
employ
investig
irradi
autolog
cancer
cell
use
fragment
pathogen
dna
introduct
synthet
viru
dna
inclus
synthet
peptid
specif
cancer
call
therapeut
vaccin
mean
medic
destin
antigen
protein
antibodi
passiv
immun
act
exist
diseas
infect
low
amount
high
extent
specif
even
spite
intens
conduct
investig
stabl
result
use
therapeut
vaccin
perhap
expect
near
futur
farther
might
explain
fact
work
therapeut
vaccin
began
compar
recent
around
well
insuffici
knowledg
mechan
action
therapeut
vaccin
differ
diseas
increas
amount
activ
lymphocyt
cellkil
select
obliter
tumor
cell
might
expect
mechan
impact
therapeut
vaccin
tumor
cell
upon
peror
administr
seen
fig
begin
present
antigen
surfac
dc
cellkil
cellhelp
descend
mhc
class
ii
prime
lymphocyt
killer
prime
lymphocyt
helper
destroy
tumor
cell
current
earli
gene
focu
numer
investig
base
fact
mani
attempt
made
creat
therapeut
vaccin
cervic
cancer
establish
earli
protein
regul
transcript
site
earli
polyadenyl
sign
e
mean
antitermin
occur
fig
antitermin
allow
polymeras
pass
site
pa
e
increas
transcript
late
gene
encod
synthesi
capsid
protein
hpv
accumul
larg
amount
fullsiz
capsid
protein
admit
process
success
assembl
well
packag
dna
genom
capsid
must
special
organ
spatial
function
role
earli
protein
establish
yet
later
shown
hpv
transcript
regul
sequenc
encod
transform
oncogen
protein
three
site
bind
present
space
region
site
bind
enhanc
tata
box
site
bind
enhanc
fourth
site
bind
protein
whole
zone
tata
box
destin
region
origin
replic
perhap
particip
process
essenti
transcript
oper
block
initi
replic
besid
role
protein
known
role
direct
bind
viral
genom
via
transactiv
domain
chromatin
host
cell
mean
appropri
kinas
dual
role
protein
propos
regul
cancerogenesi
blocker
initi
replic
ori
site
mediat
hold
ring
genom
papillomaviru
close
chromatin
mcbride
jang
protein
earli
express
name
transform
protein
direct
mammalian
cell
increas
prolif
activ
neoplasia
protein
multifunct
activ
howev
characterist
featur
initi
cancerogenesi
suppos
interact
protein
call
tumor
suppressor
protein
interact
protein
prb
retinoblastoma
consid
key
step
initi
cell
prolifer
prb
join
lost
connect
eukaryot
factor
initi
replic
liber
activ
cyclindepend
kinas
cdk
occur
cell
cycl
shift
stage
dna
synthesi
protein
express
cultur
prime
cell
cin
keratinocyt
acquir
behavior
immort
prolifer
immort
cultur
keratinocyt
protein
small
amino
acid
size
kda
structur
zincfing
evid
function
factor
transcript
site
spite
small
size
epitop
structur
protein
evid
capabl
evok
immun
respons
format
neutral
antibodi
due
manifest
presenc
epitop
propos
role
protein
therapeut
vaccin
earli
protein
induc
synthesi
specif
antibodi
immun
mice
reveal
special
select
hpv
type
consid
possibl
candid
creation
vaccin
mani
type
papillomavirus
base
earli
obtain
mainli
e
coli
cell
baculovir
express
system
synthesi
protein
abund
therefor
molecul
assembl
dimer
trimer
oligom
complic
order
associ
particl
experi
studi
immun
activ
mostli
neg
order
increas
immun
respons
adjuv
ad
thu
propos
inact
immun
respons
contradict
presenc
mani
epitop
linear
conform
structur
establish
fact
bind
prb
whole
seri
investig
follow
confirm
cancerogenesi
inject
solut
mice
therefor
believ
respons
moreov
tumorigenesi
follow
infect
high
oncogen
type
papillomavirus
work
italian
scientist
togeth
v
yusibov
usa
shown
applic
receiv
plant
viru
express
system
develop
tobacco
plant
result
regress
lymphoma
visibl
decreas
size
disappear
venuti
et
al
author
announc
usag
tobacco
leav
candid
therapeut
pmv
tumorigenesi
dual
role
hpv
propos
induct
tumorigenesi
induct
synthesi
specif
neutral
antibodi
reject
tumor
mice
given
three
time
interv
week
mkg
protein
week
later
last
administr
mice
inject
tumor
cell
howev
mice
form
tumor
although
control
form
tumor
inject
mice
vaccin
one
dose
introduc
afterward
small
tumor
appear
indic
care
palpat
petron
et
al
author
natur
conclud
due
dual
role
protein
tumorigenesi
might
success
model
creation
therapeut
vaccin
cancer
present
time
larg
amount
clinic
trial
conduct
differ
combin
use
mani
variant
adjuv
dna
vaccin
peptid
sever
sourc
small
size
also
allow
obtain
synthesi
differ
express
system
aliv
viral
vector
far
awar
even
healthi
mice
infect
high
oncogen
type
papillomavirus
abl
clear
papillomavirus
year
issu
regul
event
lead
cancerogenesi
infect
otherwis
therapi
exist
cancerogenesi
conclud
mostli
state
immunoreact
function
immun
system
whole
therefor
issu
still
complic
far
need
investig
product
protein
shown
work
rybicki
coauthor
whitehead
et
al
low
reason
instabl
tobacco
plant
gene
encod
protein
without
bind
prb
site
introduc
genet
construct
selfassembl
domain
protein
corn
introduc
agrobacteri
transient
transform
product
target
protein
compos
much
gkg
tobacco
leav
presenc
antisilenc
sequenc
construct
plasmid
zera
facilit
sharp
increas
amount
target
protein
compon
zera
reveal
immunogen
activ
otherwis
whole
complex
bodi
synthes
tobacco
leav
led
regress
tumor
mice
therefor
candid
therapeut
vaccin
cervic
cancer
creat
base
complex
whitehead
et
al
success
clinic
trial
pmv
volunt
conduct
pandem
influenza
unit
state
recombin
antigen
protein
hemagglutinin
influenza
viru
produc
plant
viru
express
system
tobacco
plant
use
tmv
replicas
jullarsen
et
al
number
volunt
inject
deltoid
muscl
ml
prepar
solut
purifi
extract
tobacco
leav
analysi
blood
serum
lymphocyt
indic
presenc
specif
neutral
antibodi
increas
level
interleukin
interferon
began
work
oncogen
develop
construct
creation
candid
vaccin
express
tomato
fruit
transform
combin
agrobacteri
plant
viral
system
first
experi
show
creat
genet
construct
provid
express
target
gene
synthesi
antigen
protein
transgen
plant
upon
agrobacteri
transform
sum
statement
might
conclud
innov
biotechnolog
employ
method
molecular
biolog
genet
engin
open
new
possibl
creation
new
type
prevent
therapeut
vaccin
whose
elabor
research
work
intens
laboratori
mani
countri
synthes
fullsiz
antibodi
antibodi
reduc
size
miniantibodi
singl
chain
fragment
antibodi
expens
event
requir
besid
financi
support
bulk
seriou
knowledg
molecular
biolog
genet
biochemistri
protein
immunolog
therefor
suitabl
methodolog
recombin
biotechnolog
employ
express
vector
place
one
express
system
appear
found
bacteri
yeast
express
system
simpl
mostli
diagnost
minibodi
fab
fragment
carri
immunodetermin
could
obtain
possibl
synthes
function
activ
fullsiz
antibodi
react
complement
protein
bacteri
yeast
express
system
appropri
fold
well
due
insuffici
isomer
absenc
glycosyl
proper
mammal
plant
express
system
turn
overcom
disadvantag
fortun
abl
synthes
exact
antibodi
cell
mammal
cultur
order
provid
correct
fold
isomer
glycosyl
hiat
pauli
monoclon
antibodi
use
two
direct
mean
passiv
immun
high
specif
microbicid
remedi
appli
suppos
place
infect
monoclon
antibodi
began
produc
corn
seed
rice
seed
seed
leav
arabidopsi
produc
antibodi
effect
monoclon
antibodi
form
mammalian
cell
cultur
cho
cell
hamster
ovari
take
account
easier
scalabl
cost
monoclon
antibodi
produc
plant
plantibodi
suggest
time
lower
et
al
mean
recombin
technolog
highli
effect
broad
neutral
antibodi
hiv
creat
cho
consid
necess
antibodi
kgyear
therapeut
prevent
mean
order
control
expans
hiv
world
mammalian
cell
cultur
cho
abl
provid
product
larg
amount
antibodi
et
al
suggest
employ
plant
viru
express
system
product
microbicid
base
tobacco
plant
produc
mkgg
fresh
weight
first
gener
plant
mkgg
fresh
weight
second
gener
plant
clinic
trial
reveal
microbicid
base
plantderiv
antibodi
toxic
women
even
appli
amount
mkg
intravagin
use
replicas
bean
yellow
mosaic
viru
bemv
dna
genom
express
system
synthesi
eic
ebola
viru
creat
tobacco
leav
bhoo
et
al
accord
design
genet
construct
glycoprotein
ebola
viru
connect
c
termin
heavi
chain
human
monoclon
antibodi
igg
specif
join
linear
gpi
construct
place
agrobacteri
vector
transform
rate
synthesi
antibodi
high
agroinfect
day
accumul
mkgg
fresh
weight
tobacco
leav
dose
mkg
eic
ebola
glycoprotein
inject
linear
mice
guinea
pig
gave
defens
ebola
viru
howev
trial
human
primat
charl
arntzen
publish
studi
shown
eic
tobacco
leav
success
appli
volunt
time
ebola
epidem
africa
peopl
die
diseas
scientist
also
shown
success
antibodi
glycosyl
activ
join
ebola
viru
arntzen
present
time
larg
number
investig
carri
glycoengin
plantibodi
order
elicit
posttransl
modif
mucos
antibodi
biosimilar
human
glycosyl
final
purpos
succeed
mucos
passiv
immun
iga
igm
work
mostli
direct
commerci
exploit
plant
express
system
creation
biopharmaceut
passiv
immun
mani
infecti
diseas
vasilev
et
al
far
final
critic
mileston
must
trial
human
investig
still
stage
research
attempt
decid
physicalchem
pharmacolog
peculiar
glycosyl
mucos
antibodi
passiv
immun
antibodi
plant
pathogen
consid
exploit
order
overcom
bare
patch
rhizoctonia
solani
pathogen
excit
plant
diseas
plant
transient
express
system
current
declar
mobil
reliabl
system
develop
medica
might
turn
scalabl
success
compar
exist
recombin
express
system
employ
system
much
kg
vaccin
biomassyear
content
target
antigen
protein
mkg
per
g
fresh
weight
produc
necess
larg
product
antigen
protein
antibodi
appear
outbreak
diseas
epidem
eg
ebola
viru
cholera
leishmaniosi
threat
bioterror
spite
highli
evidenc
advantag
pmv
one
vaccin
cholera
receiv
fda
approv
perhap
appli
peopl
eg
iraq
first
stage
clinic
trial
pmv
influenza
pandem
season
rabi
norwalk
viru
hepat
b
tabl
conflict
interest
author
classic
inject
nasalpharyng
vaccin
make
reason
slow
introduct
pmv
popul
aim
prophylaxi
therefor
demand
ascertain
pmv
mechan
transfer
belong
classic
inject
vaccin
dosag
prepar
vaccin
formul
administr
transport
storag
stabil
temperatur
impact
schedul
vaccin
usag
adjuv
besid
necessari
continu
studi
optim
glycosyl
vaccin
use
udptransferas
broad
specif
perhap
futur
would
advis
appli
consequ
prevent
follow
therapeut
vaccin
prevent
vaccin
would
satisfi
investig
direct
seem
great
import
